Chia-Jui Weng Selected Research

Chia-Jui Weng Research Topics

Disease

14	Neoplasms (Cancer) 01/2018 - 06/2009
8	Hepatocellular Carcinoma (Hepatoma) 08/2012 - 01/2008
6	Mouth Neoplasms (Oral Cancer) 01/2020 - 10/2010
6	Neoplasm Metastasis (Metastasis) 08/2012 - 06/2009
4	Adenocarcinoma of Lung 05/2013 - 03/2009
3	Carcinogenesis 01/2019 - 06/2009
3	Inflammation (Inflammations) 01/2016 - 10/2010
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2019
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 07/2019
1	Nasopharyngeal Carcinoma 07/2019
1	Disease Progression 01/2019
1	Pneumonia (Pneumonitis) 01/2016
1	Asthma (Bronchial Asthma) 01/2016
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 06/2011
1	Lymphatic Metastasis 03/2011
1	Lung Neoplasms (Lung Cancer) 06/2009
1	Carcinoma (Carcinomatosis) 06/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 07/2019 - 07/2010
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2010
5	PhytochemicalsIBA 01/2018 - 02/2012
4	ResveratrolIBA 02/2012 - 03/2009
3	Environmental CarcinogensIBA 01/2019 - 03/2011
3	cinnamic acidIBA 05/2013 - 10/2011
3	gingerolIBA 08/2012 - 11/2010
3	shogaolIBA 08/2012 - 11/2010
3	Matrix Metalloproteinases (MMPs)IBA 08/2012 - 08/2011
3	AcidsIBA 02/2012 - 01/2008
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2011 - 11/2010
2	CarcinogensIBA 01/2019 - 12/2012
2	allyl sulfideIBA 01/2016 - 05/2014
2	amsonic acid (DAS)IBA 01/2016 - 05/2014
2	Cathepsin BIBA 11/2014 - 12/2012
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2014 - 01/2008
2	FlavonoidsIBA 06/2012 - 02/2012
2	Plasminogen Activators (Plasminogen Activator)IBA 03/2011 - 12/2010
2	Tissue Inhibitor of Metalloproteinase-1IBA 11/2010 - 03/2010
1	ErianinIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	licochalcone AIBA 07/2019
1	Mitogen-Activated Protein KinasesIBA 07/2019
1	Cytostatic AgentsIBA 07/2019
1	CaspasesIBA 07/2019
1	Leptin ReceptorsIBA 01/2019
1	LeptinIBA 01/2019
1	glabridinIBA 06/2018
1	AllergensIBA 01/2016
1	AntioxidantsIBA 01/2016
1	OvalbuminIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014
1	EnzymesIBA 05/2014
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 05/2014
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2014
1	Histamine (Histamine Dihydrochloride)FDA Link 05/2014
1	Cysteine Proteases (Cysteine Protease)IBA 12/2012
1	Apoptosis Regulatory ProteinsIBA 07/2012
1	SurvivinIBA 07/2012
1	Collagenases (Collagenase)FDA Link 07/2012
1	Catechin (Z 7300)IBA 06/2012
1	naringeninIBA 06/2012
1	kaempferolIBA 06/2012
1	myricetinIBA 06/2012
1	genistinIBA 06/2012
1	gallocatechol (epigallocatechin)IBA 06/2012
1	tangeretinIBA 06/2012
1	glyciteinIBA 06/2012
1	licoricidinIBA 06/2012
1	Silybin (Lagosa)IBA 06/2012
1	Anthocyanins (Anthocyanin)IBA 06/2012
1	daidzeinIBA 06/2012
1	QuercetinIBA 06/2012
1	GenisteinIBA 06/2012
1	ApigeninIBA 06/2012
1	LuteolinIBA 06/2012
1	CurcuminIBA 02/2012
1	Gallic AcidIBA 02/2012
1	PolyphenolsIBA 02/2012
1	Capsaicin (Zostrix)FDA Link 02/2012
1	caffeic acidIBA 02/2012
1	Chlorogenic AcidIBA 02/2012
1	carnosolIBA 02/2012
1	Peptide Hydrolases (Proteases)FDA Link 08/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2011
1	Plasminogen InactivatorsIBA 03/2011
1	Plasminogen Activator Inhibitor 1IBA 03/2011
1	Urokinase Plasminogen Activator ReceptorsIBA 03/2011
1	PlasminogenIBA 11/2010
1	LigandsIBA 10/2010
1	CytokinesIBA 10/2010
1	CC ChemokinesIBA 10/2010
1	CCR5 Receptors (CCR5 Receptor)IBA 10/2010
1	ChemokinesIBA 10/2010
1	Insulin-Like PeptidesIBA 07/2010
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2010
1	Protein Kinases (Protein Kinase)IBA 05/2010
1	Phosphotransferases (Kinase)IBA 05/2010
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2010
1	Tissue Inhibitor of Metalloproteinase-2IBA 03/2010
1	dibenzoylmethaneIBA 06/2009

Therapy/Procedure

2	Chemoprevention 02/2012 - 06/2009